DxTerity Company

DxTerity Diagnostics is focused on simplifying genomic testing -- bringing the power of personalized medicine to routine medical care.
The DxTerity technology, DxDirectTM, is a simple, fast and affordable technique for analysis of complex gene signatures. DxDirectTM combines a robust chemical ligation process, NEATTM , and a unique sample stabilization system, DxCollectTM. This enable direct from whole blood or tissue sample multiplex gene expression testing without many of the constraints that exist today.
Testing which once could only be done by a sophisticated research lab, or highly specialized and high skilled area within a clinical lab, can now be performed reliably in a routine manner by lab technicians and clinicians, all with the same level of quality. Specialties-Molecular Diagnostics, Oncology, Immune Response
Technology: Personalized Diagnostics
Industry: Precision Medicine
Headquarters: Rancho Dominguez
Founded Date: 2006
Employees Number: 11-50
Funding Status: undisclosed

Visit Website
Register and Claim Ownership